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Objectives. The purpose of this study was to describe data collected
for an industry-sponsored multicenter registry of rotational atherec .
tomy.
Background. Several new devices are in use or under develop-
ment for coronary atherectomy. The clinical role for each is in
part defined by descriptive registry data.
Methods. We describe results in 709 consecutive patients
undergoing 743 procedures representing 874 lesions . The majority
of lesions were in the left anterior descending coronary artery .
Lesion morphology was described as eccentric (61 .1%), calcified
(32%), tortuous (26.6%) and long (24.9%), with previous interven-
tion in 32.7%.
Results. Overall procedural success rate, including lesions
treated with rotational atherectomy alone and with balloon angio-
plasy was 94.7% and did not vary between lesion type, location,
characteristics or severity . Previously treated lesions had a sig-
nificantly higher success rate (97 .49o', p = 0.04) than new lesions .
Major complications, including death 0.8% (95% confidence in-
terval [CI] 0.3% to 1.7%), Q wave myocardial infarction 0.97c
(95% CI 0.4% to 1.9%) and emergent coronary artery bypass
Treatment of coronary artery disease has changed significantly
since the advent of angioplasty in 1977. The development of
atherectomy technology has offered a new approach to coro-
nary lesions, with the ultimate utility of the technique still not
fully defined. Rotational atherectomy, developed by Auth in
the early 1980s, utilizes a sized burr coated with --10-µm
diamond chips. This over-the-wire system is rotated in the area
of stenosis at 180,000 to 200,000 rpm . Because of the high
speed and small cutting surfaces, the particles produced are
small, and no attempt is made to physically remove them from
the coronary circulation . Rotational atherectomy is designed
to utilize the property of differential cutting whereby inelastic
material, such as plaque, is preferentially ablated rather than
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surgery 1.7% (95% CI 0.9% to 3 .011b), were similar to other reported
devices and wen associated with length and number of lesions
treated. DNWQ wave myocardial infarction occurred in 3.8% of
patients and was significantly associated with femiRe gender and
history of previous myocardial infarction . Abrupt occlusion occurred
in 3.1% of patients and was significantly associated with bifurcated
lesions and the use of adjunctive therapy. Angiographic evidence of
dissection was seen in 10.5% (99% CI 8.3% to 12
.79o') of patients and
was significantly associated with more complex lesions, such as
eccestrir, long, calcified and American College of Cardiology/
American Heart Association type C lesions . Overall restenosis rate
was 37,7%, determined with &month anglography, representing 64 0/t,
of treated lesions . Higher restenosis rates were associated only with
poorer initial treatment outcome, diabetes and lower follow-up
angiographic rate per reporting center.
Conclusions. Rotational achenctomy appears to be a safe
method of treatment with a high success rate in a broad spectrum
of lesion types, with restenosis rates similar to other techniques .
Further conclusions will require randomized trials .
(J Am Call Cardiol 1994;24:641-8)
elastic material, such as normal arterial wall . The catheter is
also designed to access tortuous and distal segments by virtue
of a flexible helical drive shaft .
Results from a small group of 42 patients undergoing rota-
tional atherectomy were recently reported (1), as well as a larger
single-center group of 302 patients (2). The current report
describes the acute results of rotational atherectomy, clinical and
angiographic complications and 6-month angiographic restenosis
rates in an expanded group of 709 patients derived from an
industry-sponsored multicenter registry .
Methods
Patients. A multicenter registry was established in 1988
and subsequently included 17 centers in a standardized proto-
col of rotational atherectomy . Data collection ended in No-
vember 1991. The study included 709 consecutive patients
undergoing 743 procedures involving a total of 874 lesions
(Table 1). Patient selection was dictated by protocol to include
lesions >70% reduction in lumen diameter . Exclusion criteria
included acute myocardial infarction, angiographic assessment
of the presence of thrombus or dissection, lesion length
0735-10971941$7 .00
'Total varies because of missing values . Pis = patients
.
>25 mm, ejection fraction <30%, saphenous venous bypass
grafts, unprotected left main coronary artery lesions or the
inability to give informed consent . The protocol was approved
by the institutional review board on November 8, 1988 .
Operator technique. Rotational atherectomy was carried
out with the Rotablator (Heart Technology Inc.) . Premedica-
tion included aspirin and a calcium-channel blocking agent .
Nitroglycerin was given topically, intravenously or by intra-
coronary route at the discretion of the investigator . Heparin
administration was carried out, and the activated clotting time
was maintained at >300 s . All patients received venous access
through the groin, and a 9F or IOF arterial sheath was utilized .
Commercially available 9F or IOF giant-lumen guide catheters
were utilized, usually with sideholes . A 0 .1)))9-in. (11023-cm)
Rotablator guide wire was used in all cases, and in no case was
balloon predilation performed ; rather, the Rotablator was
advanced to the lesion and activated at l8tl,0OO to 2(10,000 rpm .
A stepped-burr technique was used by most investigators, using
two or more burrs to achieve the maximal desired lumen diam-
eter (average 2.1). Maximal burr diameter was measured or
estimated at 75% of the diameter of adjacent normal arterial
segments.The decision to use subsequent balloon angioplasty was
operator dependent and was for the purpose of further reduction
of lumen stenosis, reduction of arterial spasm or treatment of
angiographically evident dissection or occlusion .
Postoperatively all patients underwent heparinization for 16
to 24 h as well as receiving continued aspirin and calcium-
channel blockers . Postoperative analysis included creatine
kinase (CK) measurement every 8 h for 24 h and daily
electrocardiograms (ECGs). Discharge care was not dictated
by the protocol but in the majority of patients included
calcium-channel bk:ckers and aspirin. Angiographic follow-up
was carried out at 6 months in the absence of symptoms or
clinical signs of ischemia, or earlier as deemed appropriate by
the investigator .
Delinilion of outcome. Procedural success with the Rota-
blator alone was defined as reduction of lumen stenosis <50%
Table 2 . Characteristics of 874 Lesions
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'Total varies because of missing values .
LAD = left anterior descending
coronary artery : LCx
left circumtlex coronary arid) ; LMA - left main
coronary artery: RCA
W
right coronary artery.
in the absence of a major complication (group I) . Complemen-
tary angioplasty was defined as balloon dilation to achieve
maximal lumen diameter after successful initial rotational
atherectomy (group II). Adjunctive angioplasty was defined as
balloon dilation when required to achieve <50% residual
stenosis (group 11l). Failure was defined as inability to achieve
<50% residual stenosis or the occurrence of a major compli-
cation . All patients with a procedural failure or major compli-
cation were assigned to group IV . Major complications were
defined as procedurally related death, emergency bypass sur-
gery or Q wave myocardial infarction . Other complications
included angiographic evidence of dissection with or without
lumen compromise; non-Q wave infarction, defined as persis-
tent ST segment or T wave changes on the postprocedural
ECG or CK determination of 1 .5 times normal with a positive
myocardial band; occlusion of the vessel before or after the
intervention ; thrombus formation ; occurrence of a no-reflow
phenomenon, defined as an absent or slow distal runoff
without obvious proximal pathology; loss of side branch ;
perforation; arrhythmia ; or groin site complication requiring
surgical intervention or transfusion .
Anglographic analysis . All angiograms were initially cate-
gorized by lesion location and history of previous treatment at
the target site and were evaluated by individual operators
utilizing digital calipers for lesion severity, expressed as per-
cent of lumen diameter . Lesion calcification was defined as
angiographically visible calcium . Bifurcated lesions involved a
major or moderate-sized branch point . Long lesions were
defined as > 10 mm, tortuous as >30° angulation within the
diseased segment and eccentric as >75% of the lesion in
unilateral position . For the most recent 192 lesions included in
the study, American College of Cardiology/American Heart
Association criteria for type A, B and C lesion classification
No. of Lesions With
Characteristic.[Ibtal
No . of Lesions`
Location
LAD 433'874 49.3
RCA 257/874 29.4
LCx 1661874 19.0
LMA 181874 2.1
Long (11-25 mm) 19517.5 3 24.9
Tortuous
161/606
26 .6
Bifurcated
166 :613 27
.1
Eccentric 43_1 707 61 .1
Calcified
280714
32 .0
Type A 52.'192 27
.1
Type B 114 192 59 .4
TYpe C 26:192 13 .5
Previous treatment at site 271
.828
32 .7
Mean (=SD) pre-Rotablator 85
.3 -
11.1
slendsis (r;)
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Table 1
. Clinical Characteristics of 709 Study Patients
No. of Pis With
Characteristic;
Total No, of Pis'
Male gender
5451709 76 .9
Female gender
1641709 23 .1
Mean (±SD) age (yr) 61 .8 t 10 .6
Previous myocardial infarction 275/632 43 .5
Smoker
2181598 365
Diabetes
491220 22 .3
Hypertension
3381622 54 .3
Elevated cholesterol
.1711597 62 .1
Patients with
1 procedure
6801709 95,9
2 procedures 251709 3,5
3 procedures 3171M1 11 .4
4 procedures 1r7(19 41 .I
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Figure 1 . Treatment methods for 874
lesions : group I = treatment with rota-
tional atherectomy alone ; group II =
successful rotational atherectomy and
addition of complementary balloon
angioplasty to improve lumen diameter
or treat spasm or dissection ; group
Ill = unsuccessful atherectomy requir-
ing use of adjunctive balloon angio-
plasty to reach <50% lumen stenosis ;
group IV = unsuccessful treatment of
lesion . By definition, all major compli-
cations (death, 0 wave myocardial in-
farction and emergency bypass surgery)
are represented in group IV .
were applied (Table 2) . In follow-up angiograms, restenosis
was defined as >50% lumen diameter stenosis at the site of
rotational atherectomy .
Statistical analysis . All data were analyzed at a central
coodinating center. Chi-square analysis and cross-tabulation
were used for binary and categoric variables and unpaired t
tests to evaluate the two continuous variables of age and
percent stenosis . Any variables with statistical significance (p <
0.05) were then evaluated using logistic regression models for
success, failure, complications and 6-month restenosis . Pear-
son correlation and linear regression were used to analyze the
association of patient, lesion and operative factors on percent
restenosis of lesions at 6 months . Ninety-five percent confi-
dence intervals for the complication rate were based on the
Poisson or normal approximation to the binomial distribution .
Results
Procedural outcome. Procedural outcome was defined in
four subgroups. Figure I describes the method of treatment
and outcome for each of 874 lesions treated . In the majority of
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lesions (81%), the use of rotational atherectomy alone fulfilled
the criteria for success. In 460 of these lesions (64%), no
further treatment was undertaken (group I) . However, in 255
(36%) of these 715 angiographically successful atherectomies,
complementary angioplasty was utilized to further increase
lumen diameter or to treat spasm or dissection (group 11) . In
an additional 113 patients, use of rotational atherectomy alone
did not lead to residual stenosis <50%, but use of adjunctive
balloon angioplasty led to procedural success (group III) . An
addi* :iuai 46 lesions (5%) were not successfully treated with
any technique and were treated either medically or with
.°mergent or elective bypass surgery (group IV) . Overall,
combining groups l, II and 111, the procedural success rate was
94.7%. Either complementary or adjunctive balloon angio-
plasty was used in 44.3% of lesions.
Figure 2 demonstrates the treatment strategies and success
rates for different types of angiographically defined lesions.
Among all patient and lesion characteristics listed in Tables I
and 2, as well as procedural variables, the only factors that
were significantly associated with initial success rates in a
univariate model were the investigational center (p = 0 .01)
1
Bifurcated
Figure 2 . Success rates for various lesion types and
characteristics defined as a residual lumen stenosis
<50% in the absence of procedural complications of
death, 0 wave myocardial infarction or emergency
bypass surgery. Solid bars = Rotablator (includes all
lesions that were successfully treated with rotational
atherectomy alone, including those subsequently
treated with complementary balloon dilation to im-
prove lumen diameter [groups I and II in text]) . Open
bars = coronary angioplasty (includes lesions success-
- fully treated only after use of adjunctive angioplasty
[group III in text]) .
i
Group
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Table 3 . Incidence of Complications During 743 Procedures
'Percent of
535 because of incomplete data .
and previous treatment (higher success rate with previous
treatment, p = 0 .04). Complete occlusions, where a wire could
be placed, and ostial lesions did not have statistically signifi-
cantly different initial success rates . Where more than one
lesion was treated in a patient, there was no interdependence
between lesions in association with outcome . The continuous
variables of age and preoperative stenosis were not associated
with initial success rates . In a logistic regression model of
success rates, only the treating center was a significant variable .
The average center performed 32 procedures (range 4 to 157) .
The mean number of cases per center was 44, and the majority
of lesions (622) were treated at 10 of the 17 participating
centers . Of the 743 lesions treated, 627 (84 .4%) were treated as
one lesion, 102 (13 .7%) as two lesions, 13 (1 .7%) as three
lesions and 1 (0.1%) as four lesions in a single procedure .
Complications. There were 26 major complications in 22
procedures (3%) (Table 3). By definition, groups I, II and III
did not contain patients with major complications . All patients
with a major complication or otherwise unsuccessful result are
included in group IV . The 6 deaths in the series were attrib-
uted to arterial occlusion from spasm, thrombus or dissection
in three cases, sudden poorly tolerated reduction in left
ventricular function in two cases and vessel perforation in one
case. Q wave myocardial infarction was due to abrupt vessel
closure in three cases, delayed closure within 24 h in three and
unknown causes in one case. Three of the six patients who died
and one of the seven patients with Q wave myocardial infarc-
tion underwent emergency bypass surgery during the hospital
period. Causes of emergency bypass surgery included abrupt
occlusion in eight patients, late closure in four patients, vessel
perforation in two patients, poor distal runoff without defin-
able proximal vessel pathology (no reflow phenomenon) in one
patient and a broken guide 'wire in one patient .
Dissection, non-Q wave myocardial infarction and abrupt
JACC Vol . 24, No. 3
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occlusion constituted the majority of the remaining complica-
tions (Table 3). Severe spasm leading to occlusion or myocar-
dial infarction and requiring intervention with balloon angio-
plasty or surgical intervention was relatively rare, occurring in
1 .6% of patients, but less severe spasm treated with intracoro-
nary nitrates was a common event and not specifically or
uniformly reported by the investigators. Data for analysis of
non-Q wave myocardial infarction were available for analysis
in th .: form of CK determinations in 92 ,'/c and ECGs in 72% of
the procedures.
Statistical analysis of complications was undertaken using
patient (Table I) and angiographic characteristics (Table 2) as
well as procedural strategies, Table 4 shows the univariate and
multivariate analysis of factors significantly associated with each
of the major complications and the most common other compli-
cations. No variables were predictors of major complications
taken as a group. However, Q wave myocardial infarction was
more likely to occur in patients with two or more lesions (3 .4% vs.
0.5% for one lesion, p < 0 .05). 0 wave myocardial infarction was
also more likely to occur in lesions >10 mm in length (2 .1% vs.
0.2%, p < 0.05) . Both of these lesion characteristics were still
significant when included together in a logistic regression model
for Q wave myocardial infarction . Overall complication rates
were similar for all patient characteristics . The overall complica-
tion rates were similar for all lesion locations except the left main
coronary artery (44.4% vs . 22.8% for other locations, p < 0.05) .
Long lesions were more likely to develop a complication
(27.7%) than short lesions (20.2%, p < 0.05). The overall
complication rate in bifurcated lesions was 32 .5% versus 19.4% in
nonbifurcated lesions (p < 0 .01) . Likewise . American College of
Cardiology/American Heart Association type C lesions had a
higher overall complication rate (44%) than type A and B lesions
(22.6%, p < 0.05) .
No. of
Complications
% of 743
Procedures
95%
Confidence
Interval
Major complications (22 procedures) 3.0 1 .9-4 .5
Death 6 0.8 0.3-1 .7
0 wave myocardial infarction 7 0.9 0.4-19
CABG 13 1 .7 0.9-3 .9
Other complications (159 procedures) 21 .4 183--24.3
Dissection 78 1(1.5 8.3-12.7
Non-Q wave myocardial infarction 28 5 .2* 3.9-6.8
Acute occlusion 23 3.1 2.0-4.h
Groin complication 16 2 .2 1 .3-3 .5
Arrhythmia 14 1 .4 k .lI-3 . 2
Spasm 12 1 .1+ 8.8-2.8
Thrombosis/thromhus 12 Lh 0.8-2.8
No ref ow 9 1 .2 11 .5-2.3
( .ate occlusion 7 11 .9 9.4-I !I
Perforation 4 11 .5 11 .1-1 .4
Loss of distal side branch 1 0 .1 11.01-8.8
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Table 4. Univariate and Multivariate Analysis of Factors Associated With Complications
in 743 Procedures*
*p < 0
.05 . Ml = myocardial infarction.
Six-month angiographic follow-up . Of the 874 lesions ini-
tially treated, 828 were available for follow-up after the initial
46 failed lesions were subtracted . Elective coronary artery
bypass surgery was performed in patients representing six
lesions without further angiographic follow-up, and patients
representing 12 lesions died without angiographic follow-up .
Angiographic follow-up was performed in 527 (64%) of the
remaining 810 lesions within the 1st 6 months of the initial
procedure. Patients representing the remaining 283 eligible
lesions were either lost to follow-up or refused angiography .
The overall restenosis rate was noted to be 37 .7% .
Statistical analysis of restenosis included evaluation of
patient characteristics (Table 1), lesion location and character-
istics (Table 2) and treatment variables . Diabetes was a
predictor of restenosi ; (55 .6%% vs. 33 .7%, p < 0.05); no other
patient variables were associated . Although there was a trend
toward higher restenosis rate in left anterior descending cor-
onary artery lesions (41 .1%), this was not statistically signifi-
cant. Other lesion characteristics likewise were not associated
with a higher restenosis rate . Use of complementary or adjunc-
tive balloon angioplasty did not affect restenosis rates . How-
ever, the treating center and angiographic follow-up rates had
a statistically significant association with restenosis, with higher
follow-up rates associated with a lower restenosis rate . The
continuous variables of age and initial lesion severity were not
associated with restenosis rates . However, linear regression
analysis showed a significant association between final treat-
ment stenosis and percent stenosis at 6 months (r = 0 .21, p <
0.001). In a multivariate model, then, only the presence of
diabetes, higher final treatment stenoses and lower percent
follow-up rates per center were statistically associated with
higher restenosis rates. The statistical power of the study to
detect differences in restenosis rates for the conditions, ; n listed
Tables 1 and 2 varied considerably, depending on the number
of patients with information on the presence or absence of a
condition and the proportion of the patients with the condi-
tion. For many of the conditions listed in Tables 1 and 2,
differences in restenosis rates of 20% to 30% between those
with and without the condition would have an 80% chance of
detection at p < 0.05 . A larger series of patients would improve
the statistical power of the study and might detect further
WARM El Al_
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differences in restenosis rates between groups . For other
conditions, smaller differences in restenosis rates would have
the same 80% chance of detection . For example, tortousity,
calcification, bifurcation, length, location, previous treatment
and the risk factors of gender, smoking. previous myocardial
infarction and high cholesterol would have detectable differ-
ences of 10% to 15% for those with and without the condition .
Discussion
Success rates. Successful outcome of standard balloon
angioplasty depends on several factors that have been identi-
fied and studied, including operator experience, lesion charac-
teristics, especially calcification, lesion location, severity and
patient age (3,4). Using the American College of Cardiology/
American Heart Association classification of lesion type, suc-
cess rates between 60% and >85% can be expected (5) .
However. more recent studies have described success rates
substantially higher (4,6) . The role of the Rotablator in specific
lesion subsets compared with standard balloon angioplasty
remains to be defined . The high rotational speed utilized
during rotational atherectomy is designed to displace friction
between the burr and the arterial wall, facilitating the treat-
ment of distal, tortuous and difficult-to-cross lesions . The.
majority of lesions in the current study were described by
investigators as long, tortuous, eccentric, bifurcated or calcified
and would therefore be expected to be classified as type B or
C lesions. In the later portion of the study, where specific
lesion classification was made in 192 patients, 73% were
classified as type B or C . The current study describes an overall
success rate of 81% with the Rotahlator alone, using an
angiographically defined success rate of <50% residual steno-
sis (groups I and 11) . A similarly defined success rate of 77%
was reported in another large series using quantitative angiog-
raphy (7). The angiographic success rate was increased to 97%
in that series and to 95% in the current series with the addition
of the lesions requiring adjunctive balloon angioplasty (group
111)
. Clinically, however, the investigators utilized rotational
atherectomy as a stand-alone procedure in only 52% of lesions .
The frequent use of balloon angioplasty in either a comple-
mentary or adjunctive role suggests that rotational atherec-
Complication
Univariate
Analysis
Multivariate
Analysis
Death -
0 wave MI No . of lesions; lesion lengilr
No . of lesions ; lesion length
Coronary bypass Bifurcated lesion
Bifurcated lesion
Dissection Center: adjunctive therapy : length : eccentricity
; Center; adjunctive therapy
calcification ; type C lesion
Non-Q wave Ml
Female gender ; previous myocardial infarction
Female gender; previous myocardial
infarction
Abrupt occlusion Bifurcated lesion
: adjunctive therapy Bifurcated lesion : adjunctive therapy
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tomy is often utilized as part of a strategy of device-facilitated
angioplasty. Ultimately, the best approach in specific lesions
incorporating rotational atherectomy or balloon angioplasty .
or both, remains to be defined .
When results of all treatment modalities with rotational
atherectomy as the initial device are combined, overall success
rates for type B and C lesions were 96 .5% and 92.3%,
respectively . Other Rotablator series have shown similar re-
sults for type B and C lesions (2,8) . Other analysis has shown
an initial success rate between 91% and 95% for lesions with
calcification, tortousity, bifurcation points, or eccentricity
(9,10). Likewise, the current study defines no statistical differ-
ence for initial success rates within the group of lesion
variables studied . These data together suggest that rotational
atherectomy may be applicable in a wide variety of lesion
characteristics and yield acceptable success rates . Larger
groups of patients will be necessary to define more accurately
potential differences in success rates in lesion subsets . Also,
whether rotational atherectomy represents any improvement
over current success rates with balloon angioplasty alone will
require a randomized trial to determine, structured with a
higher degree of angiographic follow-up and with uniform core
laboratory reporting.
Mechanism of action and clinical implications . The Rota-
blator is a unique tool with a mechanism of action completely
different from other interventional modalities. The device is
specifically designed to polish or sand the internal lumen of the
artery ; however, the actual in vivo interaction of the Rotablator
with the arterial wall remains incompletely defined . Several
studies have evaluated arterial geometry and size after rota-
tional atherectomy (11-14). Mintz et al . (13) examined arterial
geometry after rotational atherectomy in a small group of
patients . A smooth, polished, tubular lumen was described,
especially in areas of densest calcium . Average lumen stenosis
of 77 11,1, was reduced to 28%, similar to angiographie findings in
the current study, Intravascular ultrasound has also been
reported to show no significant change in the diameter of the
external elastic lamina after rotational atherectomy (13-15),
suggesting that the major mechanism of action of the Rota-
blator is one of cutting rather than arterial dilation .
Finally, studies with quantitative angiography and intravas-
cular ultrasound support this hypothesis, demonstrating a lack
of elastic recoil. Ultrasound studies (16) have demonstrated
the final 24-h lumen diameter to be an average of 20% larger
than the measurement made immediately at the conclusion of
the procedure. Lumen diameter has also been demonstrated
by quantitative angiography to be up to 40% larger at 24 h than
immediately after the conclusion of the procedure (17,18),
suggesting that a release of spasm may have occurred . Multiple
causes of arterial spasm can be postulated, including humoral
mediators from either denuded endothelial cells, plaque o -
damaged circulating blood elements . Also, the potential gen-
eration of heat may play a role in vasespasm, as may the
potential high frequency vibration of the distal guide wire or
microvacuolization caused by the high speed burr interaction
with the circulating blood. Spontaneous echo contrast has been
JACC Vol 24, No . 3
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demonstrated in an in vitro model with the Rotablator used in
blood elements (19). In the current series, spasm was not
reliably reported or routinely quantified unless complete oc-
clusion occurred . However, nitroglycerin was routinely utilized
by both in peripheral and intracoronary routes, and low
pressure balloon inflation w.,-.s used to relieve spasm .
In theory, the lack of associated barotrauma might be
expected to lead to a lower incidence of dissection . However,
the reported rate of dissection at 10 .4% clearly shows that
significant trauma to the arterial lumen frequently does occur.
Whether this is more often caused by associated balloon
angioplasty or direct trauma from the Rotablator is not clearly
answered in the current study, although individual examples of
each mechanism were observed .
The interaction of microparticulate debris with the myocar-
dium is a phenomenon unique to the technique of rotational
atherectomy. Several studies have evaluated the i vei age size,
size distribution and ultimate fate of the particulate debris
created during rotational atherectomy. Early animal work (20)
defined the particle size from rabbit iliac arteries to be at least
l and < 10 µm for 98% of the debris created . In vivo canine
coronary rotational atherectomy has been shown not to pro-
duce evidence of distal emboliaation when histologic sections
were examined (21) . Human femoral arterial particles har-
vested in vivo have been measured by Lacca et al . (77) with
filters and electron microscopy to be <8 µm for 9U of the
particles and no longer than ISO to 180 µm . These same
particles injected into pig coronary arteries did not lead to
clinical or microscopic signs of embolism . Particles from
human autopsy material were produced, labeled u ith techne-
tium-99 and injected into the femoral artery of dogs by Ahn et
al . (23). Nuclear scanning subsequently revealed the majority
of particles in the lung, liver and spleen .
Particulate debris is most likely one of the causes of a positive
CK in rotational atherectomy. The current incidence of non-Q
wave myocardial infarction of 5 .2% represents the extent of CK
elevation seen over a wide range of lesion types and operator
experience. Other investigators have determined rates of CK
elevation of 85% and 13% (24,25) . A preliminary study demon-
strated elevated CK at rates of up to 19% in long lesions (20 to
102 mm) (1) . The current study also confirms the statistical
significance of the association among lesion length, elevated CK
and Q wave myocardial infarction . Other variables that may affect
CK elevation include the size of the distal arterial bed available
for clearing particulate debris, the presence of spasm, operator
technique, as well as other unknown factors .
Restenosis. Restenosis data are perhaps the most difficult
to analyze, particularly in comparison with other techniques .
The patient cohort, method of analysis, definition and angio-
graphic follow-up rate each can have a major impact on the
reported incidence of restenosis (26) . In the current study,
diabetes was associated with a higher restenosis rate, a feature
seen in several studies involving balloon angioplasty as well
(27) . Better initial results also were noted to be associated with
a lower restenosis rate, as has also been previously defined with
balloon angioplasty (28,29). Finally . more complete follow-up
JACC Vol 24, No . 3
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in a given center was statictically associated with a lower
restenosis rate for that center. In studies of balloon angioplasty
where angiographic end points are used at 6 months, restenosis
rates have varied between 30% and 49% (26,30- 32). The
largest series that used the same angiographic definition of
restenosis as the current series at 6 months is reported by
Tcheng et al . (33) from Duke University . In their series of
1,364 consecutive patients with successful angioplasty, the
overall restenosis rate was 39%, with an 86% angiographic
follow-up rate . However, because a large number of variables
are potentially involved in determining restenosis rates, only a
randomized trial between balloon angioplasty and rotational
atherectomy in a selected group of patients will provide
meaningful answers with regard to relative restenosis rates .
Study limitations. Several limitations of the current study
should be kept in mind when interpreting the data presented .
First, the data collection spans a time period when clinical
experience with the Rotablator device was in its infancy, and
during which case selection and Operator technique changed
significantly (1) . In future studies, a more uniform approach
may impact the reported results. Second, analysis of the initial
and follow-up angiograms did not utilize a blinded observer or
core laboratory, and quantitative coronary angiography was
not uniformly ittilized . Likewise, although there was a random
chart audit of 25% of the data collection as part of the
protocol, there was no use of a core analysis laboratory for
ECG or CK analysis . The lack of core laboratory analysis of
data may adversely affect the accuracy of reported outcomes .
Third, the use of balloon angioplasty in 44% of the cases
reported and differences in operator criteria for utilizing
complementary angioplasty introduce an additional variable in
interpreting the data . Fourth, the 6-month angiographic fol-
low-up rate of 64% may be associated with a significant error
in reported restenosis rate. Finally, comparisons with historical
controls utilizing other techniques are of limited value, partic-
ularly in view of the lack of data in the current study with regard
to baseline characteristics such as left ventricular function .
The current study was intended to provide an early descrip-
tion of the use of a new interventional device. However, these
study limitations clearly point to the need for a randomized
protocol involving rotational atherectomy and balloon angio-
plasty . As part of a randomized trial comparing the device with
other techniques, cost data, which were not collected in the
current study, would be useful in helping to determine the
appropriate clinical niche of rotational atherectomy .
We thank Dawn Tevis for data coordination, Michaelcne
Decistra, RN . MSN,
for clinical assistance, Cheryl Williamson for manuscript
preparation and David
Criss for preparation of the illustrations
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